Equities Research Analysts’ Price Target Changes for November 6th (ACAD, ATYR, DOCS, ENOV, ETON, EVCM, EVEX, FOUR, FROG, GMED)

Equities Research Analysts’ price target changes for Friday, November 6th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its target price boosted by Canaccord Genuity Group from $36.00 to $38.00. Canaccord Genuity Group currently has a buy rating on the stock.

aTyr Pharma (NASDAQ:ATYR) had its price target trimmed by Royal Bank Of Canada to $6.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Doximity (NYSE:DOCS) had its target price increased by Canaccord Genuity Group from $36.00 to $40.00. The firm currently has a buy rating on the stock.

Enovis (NYSE:ENOV) had its price target trimmed by Canaccord Genuity Group from $45.00 to $42.00. The firm currently has a buy rating on the stock.

Eton Pharmaceuticals (NASDAQ:ETON) had its target price increased by Canaccord Genuity Group from $68.00 to $80.00. The firm currently has a buy rating on the stock.

EverCommerce (NASDAQ:EVCM) had its target price trimmed by Canaccord Genuity Group from $13.00 to $9.00. Canaccord Genuity Group currently has a buy rating on the stock.

EVE (NYSE:EVEX) had its price target trimmed by Canaccord Genuity Group from $7.50 to $7.00. The firm currently has a buy rating on the stock.

Shift4 Payments (NYSE:FOUR) had its price target trimmed by Royal Bank Of Canada from $67.00 to $49.00. They currently have an outperform rating on the stock.

JFrog (NASDAQ:FROG) had its target price raised by Canaccord Genuity Group from $105.00 to $110.00. Canaccord Genuity Group currently has a buy rating on the stock.

Globus Medical (NYSE:GMED) had its price target reduced by Canaccord Genuity Group from $115.00 to $105.00. Canaccord Genuity Group currently has a buy rating on the stock.

Holley (NYSE:HLLY) had its price target cut by Canaccord Genuity Group from $7.00 to $5.00. Canaccord Genuity Group currently has a buy rating on the stock.

Interparfums (NASDAQ:IPAR) had its price target increased by Canaccord Genuity Group from $151.00 to $154.00. They currently have a buy rating on the stock.

LifeStance Health Group (NASDAQ:LFST) had its target price increased by Canaccord Genuity Group from $15.00 to $16.00. The firm currently has a buy rating on the stock.

Lyft (NASDAQ:LYFT) had its price target lowered by Scotiabank from $17.00 to $16.00. Scotiabank currently has a sector perform rating on the stock.

Madison Air Solutions (NYSE:MAIR) had its target price reduced by Royal Bank Of Canada from $35.00 to $29.00. The firm currently has an outperform rating on the stock.

Middleby (NASDAQ:MIDD) had its price target increased by Canaccord Genuity Group from $152.00 to $160.00. The firm currently has a buy rating on the stock.

Martin Marietta Materials (NYSE:MLM) had its target price cut by Royal Bank Of Canada from $530.00 to $520.00. They currently have a sector perform rating on the stock.

MannKind (NASDAQ:MNKD) had its price target boosted by Royal Bank Of Canada from $4.75 to $5.00. The firm currently has a sector perform rating on the stock.

N-able (NYSE:NABL) had its target price boosted by Royal Bank Of Canada from $4.00 to $5.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

N-able (NYSE:NABL) had its target price boosted by Scotiabank from $3.65 to $5.45. The firm currently has a sector perform rating on the stock.

Niagen Bioscience (NASDAQ:NAGE) had its target price trimmed by Canaccord Genuity Group from $9.00 to $7.00. The firm currently has a buy rating on the stock.

NIKE (NYSE:NKE) had its price target lowered by Royal Bank Of Canada from $40.00 to $39.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Insight Enterprises (NASDAQ:NSIT) had its price target increased by Canaccord Genuity Group from $140.00 to $175.00. Canaccord Genuity Group currently has a hold rating on the stock.

NetScout Systems (NASDAQ:NTCT) had its price target lowered by Royal Bank Of Canada from $43.00 to $35.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

Prestige Consumer Healthcare (NYSE:PBH) had its target price cut by Canaccord Genuity Group from $72.00 to $70.00. Canaccord Genuity Group currently has a buy rating on the stock.

Planet Fitness (NYSE:PLNT) had its target price increased by Royal Bank Of Canada from $60.00 to $70.00. They currently have an outperform rating on the stock.

Pulse Biosciences (NASDAQ:PLSE) had its target price increased by Canaccord Genuity Group from $58.00 to $74.00. They currently have a buy rating on the stock.

Privia Health Group (NASDAQ:PRVA) had its price target boosted by Canaccord Genuity Group from $32.00 to $33.00. The firm currently has a buy rating on the stock.

Pyxis Oncology (NASDAQ:PYXS) had its price target boosted by Royal Bank Of Canada from $6.00 to $7.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Reformation (NYSE:REF) had its price target raised by Royal Bank Of Canada from $18.00 to $21.00. They currently have an outperform rating on the stock.

Sunrun (NASDAQ:RUN) had its target price trimmed by Royal Bank Of Canada from $11.00 to $10.00. They currently have an outperform rating on the stock.

Rayonier (NYSE:RYN) had its price target boosted by Royal Bank Of Canada from $20.00 to $22.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

SolarEdge Technologies (NASDAQ:SEDG) had its target price lowered by Royal Bank Of Canada from $30.00 to $25.00. Royal Bank Of Canada currently has a sector perform rating on the stock.

NuScale Power (NYSE:SMR) had its price target reduced by Royal Bank Of Canada from $7.00 to $5.00. They currently have a sector perform rating on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its target price raised by Royal Bank Of Canada from $17.00 to $18.00. They currently have a sector perform rating on the stock.

StepStone Group (NASDAQ:STEP) had its target price increased by Royal Bank Of Canada from $65.00 to $68.00. The firm currently has an outperform rating on the stock.

Teleflex (NYSE:TFX) had its target price boosted by Royal Bank Of Canada from $155.00 to $175.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Ternium (NYSE:TX) had its price target increased by Scotiabank from $40.00 to $57.00. The firm currently has a sector perform rating on the stock.

Texas Roadhouse (NASDAQ:TXRH) had its target price lowered by Royal Bank Of Canada from $220.00 to $215.00. The firm currently has an outperform rating on the stock.

Veeva Systems (NYSE:VEEV) had its target price increased by Royal Bank Of Canada from $325.00 to $365.00. They currently have an outperform rating on the stock.

VSE (NASDAQ:VSEC) had its target price boosted by Royal Bank Of Canada from $220.00 to $225.00. They currently have an outperform rating on the stock.

Verastem (NASDAQ:VSTM) had its target price cut by Royal Bank Of Canada from $19.00 to $18.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Watts Water Technologies (NYSE:WTS) had its target price lowered by Royal Bank Of Canada from $417.00 to $397.00. Royal Bank Of Canada currently has a sector perform rating on the stock.